FDA Shifts its Position and Expresses Concern About BPA

New York Times - 1.15.10

"Government evaluations of BPA have had a contentious history. The drug agency wrote a draft report calling it safe in 2008. But shortly after that, the National Toxicology Program, part of the National Institutes of Health, said BPA was cause for “some concern,” citing the same issues that the drug agency is now agreeing to: potential effects on the brain, behavior and prostate in fetuses, infants and children.

Then the drug agency asked an independent panel of scientific advisers to review its draft report, and the panel gave it a scathing review. It accused the F.D.A. of ignoring important evidence and giving consumers a false sense of security about the chemical. The drug agency promised to reconsider BPA, and the announcement on Friday fulfilled that pledge.

“We are for the first time saying we believe there is some concern about the substance’s safety, and we’ve closed the gap between N.I.H. and F.D.A.,” Dr. Sharfstein of the F.D.A. said in an interview."

Read more here.

Comments

[e cigarette]

I am beginning to really lose all faith and credibility in the FDA. It seems to me that instead of focusing their efforts on protecting the general public they are in-turn being influenced by corporate agenda and special interest. I take everything they say with a grain of salt.